V. Della Valle

发表

The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer.

E. Brambilla, V. D. Valle, C. Larsen, 1998, Cancer research.

Mutation in TET2 in myeloid cancers.

J. Soulier, W. Vainchenker, O. Bernard, 2009, The New England journal of medicine.

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.

P. Opolon, E. Solary, W. Vainchenker, 2011, Cancer cell.

Acquired initiating mutations in early hematopoietic cells of CLL patients.

Satoru Miyano, Yuichi Shiraishi, Daniel Gautheret, 2014, Cancer discovery.

Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.

M. S. Burger, V. D. Valle, C. Larsen, 2000, Cancer research.

A novel 43-kDa glycoprotein is detected in the nucleus of mammalian cells by autoantibodies from dogs with autoimmune disorders.

D. Hernandez-Verdun, C. Larsen, V. Della Valle, 1991, Experimental cell research.

TET2-mediated 5-hydroxymethylcytosine induces genetic instability and mutagenesis.

W. Vainchenker, O. Bernard, V. Della Valle, 2016, DNA repair.

DNMT3AR882H mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice

P. Gaulard, K. Helin, O. Bernard, 2016, Leukemia.

Inactivation of the P16INK4/MTS1 gene by a chromosome translocation t(9;14)(p21-22;q11) in an acute lymphoblastic leukemia of B-cell type.

R. Berger, O. Bernard, T. Leblanc, 1996, Cancer research.

A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia.

R. Berger, V. D. Valle, V. Della Valle, 1995, Blood.

Autoimmune antibodies to hnRNPG protein in dogs with systemic lupus erythematosus: epitope mapping of the antigen.

C. Larsen, V. Della Valle, M. Soulard, 2002, Journal of autoimmunity.

hnRNP G: sequence and characterization of a glycosylated RNA-binding protein.

G. Dreyfuss, C. Bauvy, P. Codogno, 1993, Nucleic acids research.

A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies.

R. Berger, O. Bernard, C. Larsen, 1995, Oncogene.

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.

Claude Preudhomme, Daniel Birnbaum, Olivier Kosmider, 2012, Blood.

Various types of rearrangements target TLX3 locus in T‐cell acute lymphoblastic leukemia

A. Ferrando, R. Berger, V. Della Valle, 2004, Genes, chromosomes & cancer.

Identification of two DNA methylation subtypes of Waldenström's macroglobulinemia with plasma and memory B cell features.

P. Vyas, O. Bernard, T. Zenz, 2020, Blood.

The I protein of the heterogeneous nuclear ribonucleoprotein complex is a novel dog nuclear autoantigen.

C. Larsen, V. Della Valle, P. Prélaud, 1996, Journal of autoimmunity.

Combined HAT/EZH2 modulation leads to cancer-selective cell death

S. Heath, P. Flicek, E. Novellino, 2018, Oncotarget.

Nucleolar proteins identified in human cells as antigens by sera from dogs with autoimmune disorders.

C. Larsen, V. Della Valle, S. Lagaye, 1989, Experimental cell research.

PSL, a nuclear cell-cycle associated antigen is increased during retinoic acid-induced differentiation of HL-60 cells.

C. Larsen, J. Abita, V. Della Valle, 1987, Biochemical and biophysical research communications.

Mutation in TET2 in myeloid cancers.

J. Soulier, W. Vainchenker, O. Bernard, 2009, The New England journal of medicine.